Literature DB >> 6264963

A calcium-activated protease possibly involved in myofibrillar protein turnover. Isolation of a low-calcium-requiring form of the protease.

W R Dayton, J V Schollmeyer, R A Lepley, L R Cortés.   

Abstract

Two forms of calcium-activated neutral protease were isolated and purified from porcine skeletal muscle. The two forms of the protease differ markedly in their requirement for calcium with the low-calcium-requiring form showing one-half maximal activation at 45 micro M calcium while the high-calcium-requiring form shows one-half maximal activation at 0.74 micro M calcium. Additionally, they chromatograph differently on DEAE-cellulose, exhibit different mobilities in electrophoresis in a nondenaturing buffer, are affected differently by certain divalent cations, and have slightly different pH dependencies. Despite these differences, the purified forms of the calcium-activated protease co-chromatograph in gel permeation chromatography, have identical banding patterns on sodium dodecyl sulfate (SDS)-polyacrylamide gels, cross-react with an antibody directed against the 80 000-dalton subunit of the calcium-activated protease we originally purified from skeletal muscle (Dayton, W.R., Goll, D.E., Zeece, M.G., Robson, R.M. and Reville, W.J. (1976) Biochemistry 15, 2150-2158), and have identical effects on the ultrastructure of myofibrils. THe high-calcium-requiring protease purified in this study is very likely identical to the calcium-activated protease we originally purified from skeletal muscle. The properties of the low-calcium-requiring form of the protease suggest that it is the form of the enzyme that is active in vivo.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6264963     DOI: 10.1016/0005-2744(81)90270-9

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  20 in total

1.  Neuromuscular recovery using calcium protease inhibition after median nerve repair in primates.

Authors:  M A Badalamente; L C Hurst; A Stracher
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

2.  A simple one-step procedure for the separation of calpain I, calpain II and calpastatin.

Authors:  J O Karlsson; S Gustavsson; C Hall; E Nilsson
Journal:  Biochem J       Date:  1985-10-01       Impact factor: 3.857

3.  Fractionation and quantification of calcium-dependent proteinase activity from small tissue samples.

Authors:  A F Clark; G N DeMartino; D E Croall
Journal:  Biochem J       Date:  1986-04-01       Impact factor: 3.857

4.  Effect of propranolol upon protein and proteolytic synthesis activity in hypertrophic myocardium.

Authors:  B Kwiatkowska-Patzer; T Zalewska
Journal:  Basic Res Cardiol       Date:  1988 Jan-Feb       Impact factor: 17.165

5.  Digestion of proteins associated with the Z-disc by calpain.

Authors:  B Bullard; G Sainsbury; N Miller
Journal:  J Muscle Res Cell Motil       Date:  1990-06       Impact factor: 2.698

6.  Purification and partial characterization of two forms of Ca2+-activated neutral protease from calf brain synaptosomes and spinal cord.

Authors:  M N Malik; M D Fenko; H M Wisniewski
Journal:  Neurochem Res       Date:  1984-02       Impact factor: 3.996

7.  Degradation of myofibrillar proteins by trypsin-like serine proteinases.

Authors:  J Kay; L M Siemankowski; R F Siemankowski; J A Greweling; D E Goll
Journal:  Biochem J       Date:  1982-02-01       Impact factor: 3.857

8.  Degradation of skeletal muscle plasma membrane proteins by calpain.

Authors:  S I Zaidi; H T Narahara
Journal:  J Membr Biol       Date:  1989-09       Impact factor: 1.843

9.  Endogenous, Ca(2+)-dependent cysteine-protease cleaves specifically the ryanodine receptor/Ca2+ release channel in skeletal muscle.

Authors:  V Shoshan-Barmatz; S Weil; H Meyer; M Varsanyi; L M Heilmeyer
Journal:  J Membr Biol       Date:  1994-12       Impact factor: 1.843

10.  Differential distribution of calpain in human lymphoid cells.

Authors:  R V Deshpande; J M Goust; N L Banik
Journal:  Neurochem Res       Date:  1993-07       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.